Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis

There is a debate whether triplet or doublet chemotherapy should be used as a first-line treatment in patients with advanced or metastatic esophagogastric cancer. Therefore, here we will review the available literature to assess the efficacy and safety of triplet versus doublet chemotherapy as a fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Haj Mohammad, N., ter Veer, E., Ngai, L., Mali, R., van Oijen, M. G. H., van Laarhoven, H. W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573655/
https://www.ncbi.nlm.nih.gov/pubmed/26267802
http://dx.doi.org/10.1007/s10555-015-9576-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573655/
https://www.ncbi.nlm.nih.gov/pubmed/26267802
http://dx.doi.org/10.1007/s10555-015-9576-y

Ejemplares similares